e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation
Anne Bergeron, Sylvie Chevret, Régis Peffault de Latour, Karine Chagnon, Constance de Margerie-Mellon, Frédéric Rivière, Marie Robin, Jean Mani, Gwenael Lorillon, Gérard Socié, Abdellatif Tazi
Source:
Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017
Journal Issue:
May
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anne Bergeron, Sylvie Chevret, Régis Peffault de Latour, Karine Chagnon, Constance de Margerie-Mellon, Frédéric Rivière, Marie Robin, Jean Mani, Gwenael Lorillon, Gérard Socié, Abdellatif Tazi. Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation. Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Noninfectious pulmonary complications of haematopoietic stem cell transplantation
Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019
Year: 2020
Pulmonary infiltrates in allogenic hematopoietic stem cell transplantation recipients
Source: Eur Respir J 2002; 20: Suppl. 38, 476s
Year: 2002
Early lung function alterations after allogeneic hematopoietic stem cell transplantation
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010
Sarcoidosis in donor-derived tissues after haematopoietic stem cell transplantation
Source: Eur Respir J 2013; 41: 1452-1453
Year: 2013
Pulmonary function in very long-term survivors after allogeneic stem cell transplantation (aSCT)
Source: International Congress 2018 – New insights in testing lung and respiratory muscle functions
Year: 2018
Respiratory infections in autologus stem cell transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 560s
Year: 2006
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Lung transplantation after allogeneic stem cell transplantation: a pan-European experience
Source: Eur Respir J, 51 (2) 1701330; 10.1183/13993003.01330-2017
Year: 2018
Asthma and atopy after allogeneic hematopoietic stem cell transplantation in children
Source: Annual Congress 2009 - Paediatric respiratory epidemiology: respiratory infections and rare diseases
Year: 2009
Lung transplantation after allogeneic bone-marrow transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 634s
Year: 2005
Lung function improvement after hematopoetic stem cell transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 173s
Year: 2007
Restrictive chronic lung function decline after haematopoietic stem cell transplantation
Source: Eur Respir J 2016; 47: 336-339
Year: 2016
Airway distensibility with lung inflation following allogeneic haematopoietic stem-cell transplantation (HSCT)
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012
Bronchiolar and pulmonary complications in recipients of bone marrow/stem cell transplantation
Source: Annual Congress 2010 - The lung in haematological disorders
Year: 2010
Late pulmonary complications after haematopoietic stem cell transplantation (HSCT) in children: incidence and risk factors
Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects
Year: 2008
Pulmonary mycobacterial infection in allogeneic hematopoietic stem cell transplanted (HSCT) patients: A study of 7 cases
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016
Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?
Source: Eur Respir J 2005; 25: 402-405
Year: 2005
Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant
Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept